Clinical Trial Update: Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms

View source ↗

Summary

A clinical trial is investigating acquired resistance to alkylator chemotherapy in neuroendocrine tumors and endocrine cancers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endocrine Cancers
• Neuroendocrine Tumors

Snippet

Sponsor: Uppsala University | Conditions: Neuroendocrine (NE) Tumors, Endocrine Cancer | Status: RECRUITING